Next Article in Journal / Special Issue
Knowledge and Educational Needs about Pre-Implantation Genetic Diagnosis (PGD) among Oncology Nurses
Previous Article in Journal
Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes
Previous Article in Special Issue
Genetic Testing in the Diagnosis of Primary Ciliary Dyskinesia: State-of-the-Art and Future Perspectives
Open AccessArticle

It’s More Than a Blood Test: Patients’ Perspectives on Noninvasive Prenatal Testing

Department of Bioethics, Cleveland Clinic, 9500 Euclid Avenue JJ60, Cleveland, OH 44195, USA
Department of Obstetrics and Gynecology, Cleveland Clinic Women's Health Institute, 9500 Euclid Avenue A81, Cleveland, OH 44195, USA
Genomic Medicine Institute, Cleveland Clinic Center for Personalized Genetic Healthcare, 9500 Euclid Avenue NE50, Cleveland, OH 44195, USA
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2014, 3(2), 614-631;
Received: 5 April 2014 / Revised: 3 May 2014 / Accepted: 6 May 2014 / Published: 19 June 2014
(This article belongs to the Special Issue Prenatal Genetic Screening and Diagnosis-Part 2)
Noninvasive prenatal testing (NIPT) offers pregnant women a new risk assessment tool for fetal aneuploidy that is superior to conventional screening tests. We conducted focus groups with women who were currently pregnant or had recently delivered in the past year to characterize their perspectives about NIPT and to explore factors they would consider during decision making about its use. Women identified accuracy, early timing, testing ease, and determination of fetal sex as advantages of NIPT over other screens, and the noninvasive method of NIPT as an advantage over diagnostic tests. False positive and false negative results, anxiety, cost and insurance coverage were seen as disadvantages of NIPT. Women who do not want fetal aneuploidy information most likely will not undergo NIPT, despite its advantages over other screening tests. However, given its advantages, the decision to have NIPT is straightforward for women who want genetic information about the fetus. Women emphasized the need to make autonomous, private, and informed choices about NIPT, as they would with any prenatal genetic testing option. These perspectives may guide clinicians to conduct effective and clinically relevant counseling with pregnant women who consider utilizing this new genetic technology. View Full-Text
Keywords: noninvasive prenatal testing; patients’ perspectives; patient decision making noninvasive prenatal testing; patients’ perspectives; patient decision making
MDPI and ACS Style

Farrell, R.M.; Mercer, M.B.; Agatisa, P.K.; Smith, M.B.; Philipson, E. It’s More Than a Blood Test: Patients’ Perspectives on Noninvasive Prenatal Testing. J. Clin. Med. 2014, 3, 614-631.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop